Q&A: The New Normal: Considerations for Restarting Research

Meghan Hosely
June 25th, 2020

Earlier in June, Advarra IRB and research compliance experts discussed key areas to consider as we look to ramp up research in the COVID-19 pandemic’s “new normal.” Presenters discussed challenges such as how to communicate with stakeholders, how to prioritize the research portfolio, and ways to ensure compliance and participant and staff safety.

Presenters participated in a Q&A session addressing audience members’ questions following the presentation. Due to the volume of questions, our experts have provided responses to some of the most popular questions.

To learn more about considerations for restarting research, read the Q&A on Advarra’s website.

Read the article